PerknElmer’s portfolio provides disease researchers the tools that enable insights and interactions between cell types and organ systems that lead to breakthroughs in prevention, early detection and treatment of diseases.
CNS research seeks to advance treatment for central nervous system disorders through the discovery and quantitation of biomarkers, mechanisms, and drug targets. ...
Over the past decade immuno-oncology (I-O) has emerged as an exciting area of personalized medicine because of its tremendous potential to harness the body’s im ...
Helping scientists unravel the complexities of cancer Cancer is not a single disease, but a complex group of hundreds of separate diseases – and the global inci ...
Cardiovascular disease is a leading cause of death globally, and understanding its causes is critical for treatment and preventative care. Our phenotypic and ta ...
The COVID-19 outbreak in December 2019 resulting from the human coronavirus SARS-CoV-2 has been spreading rapidly throughout the world and has impacted the dail ...
Inflammation is a natural marker for bodily health, and abnormal inflammatory response is indicated in an increasingly wide net of diseases and disorders, from ...
Metabolic diseases like diabetes are increasingly widespread, and research for this class of diseases relies on discovering and quantifying biomarkers to elucid ...
